• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半胱氨酸蛋白酶抑制剂 E 的结构与功能分析揭示了酶相关的二聚体和淀粉样纤维状态。

Structural and functional analysis of cystatin E reveals enzymologically relevant dimer and amyloid fibril states.

机构信息

From the Department of Biosciences, University of Salzburg, A-5020 Salzburg, Austria and.

the Center for Integrated Protein Science Munich, Technical University of Munich, D-85748 Munich, Germany.

出版信息

J Biol Chem. 2018 Aug 24;293(34):13151-13165. doi: 10.1074/jbc.RA118.002154. Epub 2018 Jul 2.

DOI:10.1074/jbc.RA118.002154
PMID:29967063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6109925/
Abstract

Protein activity is often regulated by altering the oligomerization state. One mechanism of multimerization involves domain swapping, wherein proteins exchange parts of their structures and thereby form long-lived dimers or multimers. Domain swapping has been specifically observed in amyloidogenic proteins, for example the cystatin superfamily of cysteine protease inhibitors. Cystatins are twin-headed inhibitors, simultaneously targeting the lysosomal cathepsins and legumain, with important roles in cancer progression and Alzheimer's disease. Although cystatin E is the most potent legumain inhibitor identified so far, nothing is known about its propensity to oligomerize. In this study, we show that conformational destabilization of cystatin E leads to the formation of a domain-swapped dimer with increased conformational stability. This dimer was active as a legumain inhibitor by forming a trimeric complex. By contrast, the binding sites toward papain-like proteases were buried within the cystatin E dimer. We also showed that the dimers could further convert to amyloid fibrils. Unexpectedly, cystatin E amyloid fibrils contained functional protein, which inhibited both legumain and papain-like enzymes. Fibril formation was further regulated by glycosylation. We speculate that cystatin amyloid fibrils might serve as a binding platform to stabilize the pH-sensitive legumain and cathepsins in the extracellular environment, contributing to their physiological and pathological functions.

摘要

蛋白质的活性通常通过改变寡聚状态来调节。多聚化的一种机制涉及结构域交换,其中蛋白质交换其结构的部分,从而形成长寿命的二聚体或多聚体。结构域交换已在淀粉样蛋白原蛋白中被特异性观察到,例如半胱氨酸蛋白酶抑制剂的胱抑素超家族。胱抑素是双头抑制剂,同时靶向溶酶体组织蛋白酶和组织蛋白酶 L,在癌症进展和阿尔茨海默病中具有重要作用。尽管胱抑素 E 是迄今为止鉴定出的最有效的组织蛋白酶 L 抑制剂,但对于其寡聚化倾向一无所知。在这项研究中,我们表明胱抑素 E 的构象不稳定导致形成具有增加构象稳定性的结构域交换二聚体。该二聚体通过形成三聚体复合物作为组织蛋白酶 L 抑制剂发挥活性。相比之下,针对木瓜蛋白酶样蛋白酶的结合位点被埋藏在胱抑素 E 二聚体中。我们还表明,二聚体可以进一步转化为淀粉样纤维。出乎意料的是,胱抑素 E 淀粉样纤维含有功能性蛋白质,该蛋白质抑制组织蛋白酶 L 和木瓜蛋白酶样酶。纤维形成进一步受到糖基化的调节。我们推测胱抑素淀粉样纤维可能作为结合平台,稳定细胞外环境中对 pH 敏感的组织蛋白酶 L 和组织蛋白酶,从而促进其生理和病理功能。

相似文献

1
Structural and functional analysis of cystatin E reveals enzymologically relevant dimer and amyloid fibril states.半胱氨酸蛋白酶抑制剂 E 的结构与功能分析揭示了酶相关的二聚体和淀粉样纤维状态。
J Biol Chem. 2018 Aug 24;293(34):13151-13165. doi: 10.1074/jbc.RA118.002154. Epub 2018 Jul 2.
2
Crystal structure of human cystatin C stabilized against amyloid formation.人半胱氨酸蛋白酶抑制剂 C 稳定抗淀粉样形成的晶体结构。
FEBS J. 2010 Apr;277(7):1726-37. doi: 10.1111/j.1742-4658.2010.07596.x. Epub 2010 Feb 19.
3
Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C.抑制结构域交换可阻止胱抑素C的二聚化和淀粉样纤维形成:利用工程二硫键、抗体和羧甲基木瓜蛋白酶稳定胱抑素C的单体形式。
J Biol Chem. 2004 Jun 4;279(23):24236-45. doi: 10.1074/jbc.M402621200. Epub 2004 Mar 17.
4
Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.胱抑素M/E是组织蛋白酶V和组织蛋白酶L的高亲和力抑制剂,其反应位点与天冬酰胺内肽酶结合位点不同。这为胱抑素M/E在表皮角质化中的作用提供了一个新线索。
J Biol Chem. 2006 Jun 9;281(23):15893-9. doi: 10.1074/jbc.M600694200. Epub 2006 Mar 24.
5
Domain swapping in N-truncated human cystatin C.N端截短的人胱抑素C中的结构域交换
J Mol Biol. 2004 Jul 30;341(1):151-60. doi: 10.1016/j.jmb.2004.06.013.
6
Phytocystatin 6 Forms Functional Oligomer and Amyloid Fibril States.植物半胱氨酸蛋白酶抑制剂 6 形成功能性寡聚体和淀粉样纤维状态。
Biochemistry. 2023 Dec 5;62(23):3420-3429. doi: 10.1021/acs.biochem.3c00530. Epub 2023 Nov 21.
7
Limited Proteolysis Reveals That Amyloids from the 3D Domain-Swapping Cystatin B Have a Non-Native β-Sheet Topology.有限酶解揭示 3D 结构域交换胱抑素 B 淀粉样纤维具有非天然的β-折叠拓扑结构。
J Mol Biol. 2015 Jul 31;427(15):2418-2434. doi: 10.1016/j.jmb.2015.05.014. Epub 2015 May 22.
8
Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.胱抑素E/M的低水平内化影响legumain活性和黑色素瘤细胞的迁移。
J Biol Chem. 2017 Sep 1;292(35):14413-14424. doi: 10.1074/jbc.M117.776138. Epub 2017 Jun 19.
9
Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with β-amyloid.胱抑素C寡聚体和淀粉样蛋白形成机制及其与β-淀粉样蛋白相互作用的研究进展
J Biol Chem. 2017 Jul 7;292(27):11485-11498. doi: 10.1074/jbc.M117.786558. Epub 2017 May 9.
10
Proline Residues as Switches in Conformational Changes Leading to Amyloid Fibril Formation.脯氨酸残基作为导致淀粉样纤维形成的构象变化的开关
Int J Mol Sci. 2017 Mar 7;18(3):549. doi: 10.3390/ijms18030549.

引用本文的文献

1
Cystatin 6 (CST6) and Legumain (LGMN) are potential mediators in the pathogenesis of preeclampsia.胱抑素6(CST6)和天冬酰胺内肽酶(LGMN)是子痫前期发病机制中的潜在介质。
Sci Rep. 2025 Apr 15;15(1):12945. doi: 10.1038/s41598-025-96823-9.
2
Insights into mechanisms and significance of domain swapping from emerging examples in the Mog1p/PsbP-like fold.从Mog1p/PsbP样折叠结构的新实例洞察结构域交换的机制及意义。
Biochem Biophys Res Commun. 2025 Apr 1;755:151570. doi: 10.1016/j.bbrc.2025.151570. Epub 2025 Mar 1.
3
Correlation of Experimental and Calculated Inhibition Constants of Protease Inhibitor Complexes.

本文引用的文献

1
PDBsum: Structural summaries of PDB entries.PDBsum:蛋白质数据库(PDB)条目的结构摘要。
Protein Sci. 2018 Jan;27(1):129-134. doi: 10.1002/pro.3289. Epub 2017 Oct 27.
2
Protease cleavage site fingerprinting by label-free in-gel degradomics reveals pH-dependent specificity switch of legumain.通过无标记凝胶内降解组学进行蛋白酶切割位点指纹图谱分析揭示了豆球蛋白的pH依赖性特异性转换。
EMBO J. 2017 Aug 15;36(16):2455-2465. doi: 10.15252/embj.201796750. Epub 2017 Jul 21.
3
Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.
实验和计算的蛋白酶抑制剂复合物抑制常数的相关性。
Int J Mol Sci. 2024 Feb 19;25(4):2429. doi: 10.3390/ijms25042429.
4
Type 2 Cystatins and Their Roles in the Regulation of Human Immune Response and Cancer Progression.2型胱抑素及其在人类免疫反应调节和癌症进展中的作用。
Cancers (Basel). 2023 Nov 10;15(22):5363. doi: 10.3390/cancers15225363.
5
Phytocystatin 6 Forms Functional Oligomer and Amyloid Fibril States.植物半胱氨酸蛋白酶抑制剂 6 形成功能性寡聚体和淀粉样纤维状态。
Biochemistry. 2023 Dec 5;62(23):3420-3429. doi: 10.1021/acs.biochem.3c00530. Epub 2023 Nov 21.
6
Phytocystatin 6 is a context-dependent, tight-binding inhibitor of Arabidopsis thaliana legumain isoform β.植物半胱氨酸蛋白酶抑制剂 6 是一种依赖于上下文的、紧密结合的拟南芥半胱氨酸蛋白酶体 β 同工型的抑制剂。
Plant J. 2023 Dec;116(6):1681-1695. doi: 10.1111/tpj.16458. Epub 2023 Sep 9.
7
The Mammalian Cysteine Protease Legumain in Health and Disease.哺乳动物半胱氨酸蛋白酶组织蛋白酶 L 在健康和疾病中的作用。
Int J Mol Sci. 2022 Dec 15;23(24):15983. doi: 10.3390/ijms232415983.
8
Oligomerization of Human Cystatin C-An Amyloidogenic Protein: An Analysis of Small Oligomeric Subspecies.人胱抑素 C 的寡聚化:一种淀粉样蛋白原——对小寡聚亚类的分析。
Int J Mol Sci. 2022 Nov 3;23(21):13441. doi: 10.3390/ijms232113441.
9
Structural and functional studies of legumain-mycocypin complexes revealed a competitive, exosite-regulated mode of interaction.瓜氨酸酶-麦角硫因蛋白复合物的结构和功能研究揭示了一种竞争的、外位调节的相互作用模式。
J Biol Chem. 2022 Oct;298(10):102502. doi: 10.1016/j.jbc.2022.102502. Epub 2022 Sep 16.
10
Is amyloid fibrillation related to 3D domain swapping for the C-terminal domain of SARS-CoV main protease?SARS-CoV 主蛋白酶 C 末端结构域的 3D 结构域交换是否与淀粉样纤维形成有关?
Int J Biol Macromol. 2022 Feb 1;197:68-76. doi: 10.1016/j.ijbiomac.2021.12.072. Epub 2021 Dec 22.
胱抑素E/M的低水平内化影响legumain活性和黑色素瘤细胞的迁移。
J Biol Chem. 2017 Sep 1;292(35):14413-14424. doi: 10.1074/jbc.M117.776138. Epub 2017 Jun 19.
4
Glycosylation is important for legumain localization and processing to active forms but not for cystatin E/M inhibitory functions.糖基化对于天冬酰胺酶的定位以及加工成活性形式很重要,但对于半胱氨酸蛋白酶抑制剂E/M的抑制功能则不重要。
Biochimie. 2017 Aug;139:27-37. doi: 10.1016/j.biochi.2017.05.009. Epub 2017 May 17.
5
Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease.抑制 δ-分泌酶可改善阿尔茨海默病小鼠模型的认知功能。
Nat Commun. 2017 Mar 27;8:14740. doi: 10.1038/ncomms14740.
6
THE ROLE OF CYSTEINE PROTEASE IN ALZHEIMER DISEASE.半胱氨酸蛋白酶在阿尔茨海默病中的作用
Mater Sociomed. 2016 Jun;28(3):235-8. doi: 10.5455/msm.2016.28.235-238. Epub 2016 Jun 1.
7
Evidence of Alternative Cystatin C Signal Sequence Cleavage Which Is Influenced by the A25T Polymorphism.受A25T多态性影响的胱抑素C替代信号序列切割的证据。
PLoS One. 2016 Feb 4;11(2):e0147684. doi: 10.1371/journal.pone.0147684. eCollection 2016.
8
Structure and mechanism of an aspartimide-dependent peptide ligase in human legumain.人组织蛋白酶 L 中依赖天冬酰胺酰基的肽连接酶的结构与机制
Angew Chem Int Ed Engl. 2015 Mar 2;54(10):2917-21. doi: 10.1002/anie.201409135. Epub 2015 Jan 28.
9
The amyloid state and its association with protein misfolding diseases.淀粉样状态及其与蛋白质错误折叠疾病的关联。
Nat Rev Mol Cell Biol. 2014 Jun;15(6):384-96. doi: 10.1038/nrm3810.
10
Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation.关于组织蛋白酶 L 的机制和结构研究解释了其酶原性、独特的激活途径和调控。
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):10940-5. doi: 10.1073/pnas.1300686110. Epub 2013 Jun 17.